Insmed (INSM) Change in Account Payables (2010 - 2022)
Insmed (INSM) posted quarterly Change in Account Payables of -$16.9 million for Q2 2022, down 285.64% year-over-year from $9.1 million in Q2 2021, and down 226.63% quarter-over-quarter from $13.4 million in Q1 2022.
Insmed (INSM) Change in Account Payables (2010 - 2022) Analysis & Trends
Insmed's Change in Account Payables history runs 13 years deep, the most recent figure standing at -$16.9 million for Q2 2022.
- In Q2 2022, Change in Account Payables fell 285.64% year-over-year to -$16.9 million; the TTM figure through Jun 2022 stood at $25000.0 (down 99.61% YoY), while the FY2024 annual figure was $44.6 million, up 194.24% from the prior year.
- Change in Account Payables for Q2 2022 stood at -$16.9 million, down from $13.4 million in the prior quarter.
- The five-year high for Change in Account Payables was $20.7 million in Q4 2020, with the low at -$20.3 million in Q1 2021.
- The 5-year median for Change in Account Payables is $2.0 million (2018), against an average of $977555.6.
- The sharpest annual moves came in 2019 and 2021: Change in Account Payables jumped 1247.22% in 2019, then tumbled 586.28% in 2021.
- Insmed's Change in Account Payables stood at $1.3 million in 2018, then tumbled by 577.96% to -$6.4 million in 2019, then surged by 424.73% to $20.7 million in 2020, then slumped by 45.53% to $11.3 million in 2021, then plunged by 250.02% to -$16.9 million in 2022.
- Business Quant data shows INSM's Change in Account Payables at -$16.9 million in Q2 2022, $13.4 million in Q1 2022, and $11.3 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 7.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -16.92 Mn |
| Jun 30, 2022 | -16.92 Mn |
| Mar 31, 2022 | 13.36 Mn |
| Mar 31, 2022 | 13.36 Mn |
| Dec 31, 2021 | 11.28 Mn |
| Dec 31, 2021 | 11.28 Mn |
| Sep 30, 2021 | -7.70 Mn |
| Sep 30, 2021 | -7.70 Mn |
| Jun 30, 2021 | 9.12 Mn |
| Jun 30, 2021 | 9.12 Mn |
| Mar 31, 2021 | -20.27 Mn |
| Mar 31, 2021 | -20.27 Mn |
| Dec 31, 2020 | 20.71 Mn |
| Dec 31, 2020 | 20.71 Mn |
| Sep 30, 2020 | -3.06 Mn |
| Sep 30, 2020 | -3.06 Mn |
| Jun 30, 2020 | 8.01 Mn |
| Jun 30, 2020 | 8.01 Mn |
| Mar 31, 2020 | 4.17 Mn |
| Mar 31, 2020 | 4.17 Mn |